LAZ vs MRNA · P/E 19, rev $3.19B vs rev $145.0M
Lazard Ltd (LAZ) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Lazard Ltd (LAZ) is a capital markets company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported LAZ revenue for 2025-12-31 was $3.19B. Net income was $236.8M. Revenue was up 1.5% from 2024-12-31 to 2025-12-31. LAZ currently screens at market cap $4.63B and trailing P/E 18.7.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
LAZ currently screens at market cap $4.63B and trailing P/E 18.7. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the LAZ and MRNA stock pages for the full models.
Not investment advice.